HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME Test (opens in a new window) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vázquez, E. Articles by Ortega, J. J. Search for Related Content PubMed PubMed Citation Articles by Vázquez, E. Articles by Ortega, J. J. Related Collections Neuroradiology Pediatric Radiology

Neuroimaging in Pediatric Leukemia and Lymphoma: Differential Diagnosis¹

¹ From the Department of Pediatric Radiology and Institut de Diagnòstic per la Imatge (E.V., J.L., A.C., J.P., P.S.), Department of Pediatric Hematology (T.O., J.J.O.), and Department of Pediatric Oncology (J.S.T.), Hospital Vall d’Hebron, Ps Vall d’Hebron 119–129, 08035 Barcelona, Spain. Presented as an education exhibit at the 2001 RSNA scientific assembly. Received February 18, 2002; revision requested April 26 and received June 13; accepted June 14. Address correspondence to E.V. (e-mail: evazquez@cs.vhebron.es).

Recent advances in therapy for pediatric hematologic neoplasms have greatly improved the prognosis but have resulted in an increased incidence of associated complications and toxic effects. The main neuroimaging features in pediatric patients with leukemia or lymphoma treated with chemotherapy or radiation therapy were retrospectively reviewed. To simplify the approach and facilitate differential diagnosis, the neuroimaging features have been classified into three main categories: central nervous system manifestations of primary disease, side effects of therapeutic procedures (radiation therapy, chemotherapy, bone marrow transplantation), and complications due to immunosuppression, particularly infections. Manifestations of primary disease include cerebrovascular complications (hemorrhage, cerebral infarction) and central nervous system involvement (infiltration of the meninges, parenchyma, bone marrow, orbit, and spine). Effects of radiation therapy include white matter disease, mineralizing microangiopathy, parenchymal brain volume loss, radiation-induced cryptic vascular malformations, and second neoplasms. Effects of chemotherapy and bone marrow transplantation include hemorrhage, dural venous thrombosis, white matter disease, reversible posterior leukoencephalopathy syndrome, and anterior lumbosacral radiculopathy. Both the underlying malignancy and antineoplastic therapy can cause immunosuppression. Fungi are the most frequent causal microorganisms in immunosuppressed patients with infection. Familiarity with the imaging findings is essential for proper diagnosis of neurologic symptoms in pediatric patients with oncohematologic disease.

© RSNA, 2002

Index Terms: Leukemia, complications, _**.34² • Leukemia, in infants and children, _**.34 • Lymphoma, in infants and children, _**.34 • Nervous system, infection, 10.20, 30.20 • Nervous system, neoplasms, 10.34, 30.34 • Nervous system, therapeutic radiology, 10.40, 30.40

This article has been cited by other articles:

				E. M. Chung, M. D. Murphey, C. S. Specht, R. Cube, and J. Smirniotopoulos From the Archives of the AFIP * Pediatric Orbit Tumors and Tumorlike Lesions: Osseous Lesions of the Orbit RadioGraphics, July 1, 2008; 28(4): 1193 - 1214. [Abstract] [Full Text] [PDF]

				E. Vazquez, A. Castellote, J. Piqueras, P. Ortuno, J. Sanchez-Toledo, P. Nogues, and J. Lucaya Second Malignancies in Pediatric Patients: Imaging Findings and Differential Diagnosis RadioGraphics, September 1, 2003; 23(5): 1155 - 1172. [Abstract] [Full Text] [PDF]